Figure 5. The cumulative calcium loss from the enamel specimens, when the specimens were treated daily for 3 min with 30% (w/v) slurries of the toothpastes.

Slides:

Advertisements

Similar presentations

P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.

Advertisements

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Figure Figure 18-1 part 1 Figure 18-1 part 2.

1 times table 2 times table 3 times table 4 times table 5 times table

To enhance students ability to interpret data in charts and graphs To discuss basic concepts in epidemiology and science.

$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.

Tables Learning Support

Effects of omadacycline on gut microbiota populations and Clostridium difficile germination, proliferation and toxin production in an in vitro model of.

Figure Molecular Biology of the Cell (© Garland Science 2008)

Figure 14-1 Molecular Biology of the Cell (© Garland Science 2008)

Figure 2. Reaction strategy for the synthesis of 6SLN-lipo PGA

Figure 4 Lack of protective effects of dietary supplementation with non-aggregating mutant L. crispatus MU5 on DSS colitis. DSS colitis was induced as.

Chapter 6, part B Microbial Growth.

Chapter 21: Regulation of Calcium and Magnesium

From: Mastic gum has no effect on Helicobacter pylori load in vivo

Figure 3. Time–kill curves of exponential phase P

Figure 5 Transferrin saturation, NTBI and bacterial growth in the serum of three stem cell transplantation patients, of whom one (A) did not receive apotransferrin.

Figure 6. RRs for clinical cure rates stratified by different diseases

Figure 1 Annual number of isolates of imipenem-resistant P. aeruginosa

Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:

النمو والعد البكتيري Microbial growth النمو الجرثومي.

Figures & Tables from the textbook.

Pharmacokinetics and pharmacodynamics of fluoroquinolones

Figure 1. Oxyclozanide enhances aminoglycosides and tetracycline

Enhanced antimicrobial activity of peptide-cocktails against common bacterial contaminants of ex vivo stored platelets K.V.K. Mohan, S. Sainath Rao,

Figure 1. Ten chemotherapeutic drugs induce the bacterial SOS response

Figure 1. Direct evidence for the acquisition and demise of Tn6330 by DNA sequence alignment. (a) Comparison between ... Figure 1. Direct evidence for.

Figure 1. Comparative chromosome map of the CP-hvKP strain (NUHL30457) and 10 other hvKP strains (1158, CG43, HK787, ... Figure 1. Comparative chromosome.

Figure 1. Distribution of ABCB1 SNVs and haplotypes.

Figure 1. Colistin MIC distribution for the 153 colistin-resistant E

Figure 1. Variation in population size of the donor strain HN-1 and E

Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.

Study design (A) and subject disposition (B).

Figure 1. Structure of two poxtA-carrying plasmids in E

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. SpeI-PFGE dendrogram comparing P

Figure 1. Uptake of relebactam into human OAT1, OAT3 and OCT2 stably transfected cells. Time-dependent uptake of ... Figure 1. Uptake of relebactam into.

Figure Overview.

Figure Overview.

Figure 1. Mean log10 cfu/mL versus time profile for each individual drug at 4× MIC against the four VRE ... Figure 1. Mean log10 cfu/mL versus.

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1. Susceptibility of all P

Figure 1. (a) Geographical representation of sample collection area

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Figure 1. Sequence comparison of plasmid pG38 (GenBank accession no

Figure 1 (a) Genetic backbone of pECPB39 (MG886287) and pKP13a (CP003996) plasmids. In pECPB39, the ΔproP-mcr-5.3-chrB ... Figure 1 (a) Genetic backbone.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Volume kinetics of glucose solutions given by intravenous infusion†

Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.

3 times tables.

6 times tables.

Figure 1. Outer membrane protein profiling of parental strain KJΔDEFΔ5 and its derivative fluoroquinolone-resistant ... Figure 1. Outer membrane protein.

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Figure 1. Ability of fluconazole to improve survival of G

Figure 1. Colony morphology of an A. fumigatus non-WT strain and an A

Figure 1. Time to clinical stability (a) and time to defervescence (b) in patients with pneumococcal pneumonia. ... Figure 1. Time to clinical stability.

Figure 1. The unique structures of the SCCmec type II element identified in ORSL strain CGMH-SL Figure 1. The unique structures of the SCCmec type.

Modification of prescribers’ behavior: the Icelandic approach

Figure 1. Observed mean (SD) micafungin plasma concentrations.

Figure 2. (a) Geometric mean (%CV) tenofovir diphosphate concentrations (TFV-DP in fmol/punch) in dried blood spot ... Figure 2. (a) Geometric mean (%CV)

Figure 1. Biofilm susceptibility to antibiotic treatment

Figure 1. Time–kill curves of M. abscessus CIP

Figure 1. Genetic context of blaNDM-21 on pNDM21_020023

Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer D. Zylla, M.A. Kuskowski, K. Gupta, P. Gupta

Figure 1. Percentage of samples with MDR (a), phenotypic ESBL-producing (b), fluoroquinolone-resistant (c) and ... Figure 1. Percentage of samples with.

Figure 1. CCG and practice decile and extreme percentile (1–9, 91–99) time trends, 2011–17. This figure appears in ... Figure 1. CCG and practice decile.

Presentation transcript:

Figure 5. The cumulative calcium loss from the enamel specimens, when the specimens were treated daily for 3 min with 30% (w/v) slurries of the toothpastes before demineralization. The demineralization suspensions contained approximately 0.07 mg S. mutans cell dry weight per 600 μL (OD<sub>660</sub> = 3). For the statistical analysis of the cumulative data after 5 days see the Table. Toothpastes: •, no toothpaste; ▵, Non-F; ▿, triclosan; □, NaF; ○, triclosan–NaF. From: The effect of triclosan toothpaste on enamel demineralization in a bacterial demineralization model J Antimicrob Chemother. 2000;45(2):153-158. doi:10.1093/jac/45.2.153 J Antimicrob Chemother | © 2000 The British Society for Antimicrobial Chemotherapy

Figure 1. A schematic representation of the demineralization model. From: The effect of triclosan toothpaste on enamel demineralization in a bacterial demineralization model J Antimicrob Chemother. 2000;45(2):153-158. doi:10.1093/jac/45.2.153 J Antimicrob Chemother | © 2000 The British Society for Antimicrobial Chemotherapy

Figure 2. Calcium loss (± s. d Figure 2. Calcium loss (± s.d.) from the enamel specimens when the toothpastes were diluted in the bacterial suspensions. The bacterial suspensions contained approximately 0.66 mg S. mutans cell dry weight per 600 μL (OD<sub>660</sub> = 3). Dilutions: ▪ , 10<sup>–4</sup>;▪, 10<sup>–3</sup>; □, 10<sup>–2</sup>. From: The effect of triclosan toothpaste on enamel demineralization in a bacterial demineralization model J Antimicrob Chemother. 2000;45(2):153-158. doi:10.1093/jac/45.2.153 J Antimicrob Chemother | © 2000 The British Society for Antimicrobial Chemotherapy

Figure 3. Calcium loss (± s. d Figure 3. Calcium loss (± s.d.) from the enamel specimens when the toothpastes were diluted in the bacterial suspensions. The bacterial suspensions contained approximately 0.07 mg S. mutans cell dry weight per 600 μL (OD<sub>660</sub> = 0.3). Dilutions: ▪, 10<sup>–4</sup>; ▪, 10<sup>–3</sup>; □, 10<sup>–2</sup>. From: The effect of triclosan toothpaste on enamel demineralization in a bacterial demineralization model J Antimicrob Chemother. 2000;45(2):153-158. doi:10.1093/jac/45.2.153 J Antimicrob Chemother | © 2000 The British Society for Antimicrobial Chemotherapy

Figure 4. The cumulative calcium loss from the enamel specimens, when the specimens were treated daily for 3 min with 30% (w/v) slurries of the toothpastes before demineralization. The demineralization suspensions contained approximately 0.07 mg S. mutans cell dry weight per 600 μL (OD<sub>660</sub> = 0.3). For the statistical analysis of the cumulative data after 5 days see the Table. Toothpastes: •, no toothpaste; ▵, Non-F; ▿, triclosan; □, NaF; ○, triclosan–NaF. From: The effect of triclosan toothpaste on enamel demineralization in a bacterial demineralization model J Antimicrob Chemother. 2000;45(2):153-158. doi:10.1093/jac/45.2.153 J Antimicrob Chemother | © 2000 The British Society for Antimicrobial Chemotherapy